SOMAÍ Pharmaceuticals

SOMAÍ Pharmaceuticals is a leading European pharmaceutical cannabis company with a global footprint. They are vertically integrated, meaning they control the entire process from cultivation to manufacturing and distribution. SOMAÍ is committed to crafting high-quality, EU-GMP certified cannabis-based medicines for a wide range of medical conditions. They offer a robust pipeline of innovative cannabis-based therapeutics and envision a world where people live a healthy lifestyle empowered by natural cannabis medicine.

SOMAÍ is headquartered in Lisbon, Portugal, and has a state-of-the-art manufacturing facility and indoor cultivation site. They are also actively expanding their reach through acquisitions and global brand partnerships. SOMAÍ is focused on delivering compassionate care through scientifically crafted cannabis medicines, meeting the diverse needs of fast-growing global cannabis markets. They are dedicated to providing exceptional service and are committed to working with healthcare professionals, patients, and partners to advance the field of medicinal cannabis.

SOMAÍ Pharmaceuticals is a leading European Multi-Country Operator (MCO) focused on developing and distributing cannabis-based therapeutics. They envision a world where people live healthier lives empowered by natural cannabis medicine, crafting compassionate care through scientifically advanced products. SOMAÍ is building a global brand with a robust pipeline of innovative cannabis treatments and has a state-of-the-art manufacturing facility in Portugal, with global sales teams reaching the largest medical cannabis markets.

SOMAÍ Pharmaceuticals promotes a culture focused on compassionate care and scientific innovation. They envision a world where individuals are empowered by natural cannabis medicine, emphasizing a commitment to research and development. Their vertically integrated model allows them to control the entire process, from cultivation to manufacturing, ensuring quality and ethical production. This commitment to quality and patient well-being extends to their team, creating a collaborative and dedicated environment.

SOMAÍ Pharmaceuticals has a strong commitment to diversity, equity, and inclusion, reflected in its diverse workforce and its mission to build a leading global brand with innovative cannabis-based therapeutics. They have a dedicated team with global sales representation and a state-of-the-art manufacturing facility in Lisbon, Portugal. They also partner with various stakeholders, including universities and research institutions, to advance their commitment to a world where people live healthier lives empowered by natural cannabis medicine.